story of the week
One Cycle of BEP Is Feasible for Stage I High-Risk Nonseminomatous Germ-Cell Tumors
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Annals of Oncology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Long-Term Outcome of Patients With Clinical Stage I High-Risk Nonseminomatous Germ-Cell Tumors 15 Years After One Adjuvant Cycle of Bleomycin, Etoposide and Cisplatin Chemotherapy
Ann. Oncol 2015 Feb 01;26(2)374-377, AD Vidal, GN Thalmann, E Karamitopoulou-Diamantis, MF Fey, UE StuderFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.